IBD Flashcards
What is IBD?
combination of disorder:
Crohn’s disease
Ulceratice colitis
Causes of IBD
Infectious diseases: viruses, chlamydia
Genetics: metabolic defects
Environmental factors: smoking
Immune defects: altered host susceptibility
Psychological defects: stress
What is Crohn’s disease
chronic non-inflammatory disease that most commonly affects the distal ileum and proximal colon
Signs and symptom of Crohn’s disease
-Aphthous ulcers: non-painful ulcers
-Chronic diarrhea
-Perineal fistual
-arthritis, epischoritis, skin lesions, higher risk of gall and kidney stones
What is the chronic diarrhea in Crohn’s disease associated with?
With:
abdominal pain
fever
steatorrhea
anorexia
weight loss
malnutrition
abdominal mass
Dysphagia (difficulty swallowing)
Odenphragia (painful swallowing)
watery diarrhea
B12 deficiency
What causes the gall stones in Crohn’s disease
cholesterol collects and causes its formation
What is ulcerative colitis
chronic non-specific inflammatory and ulcerative disease occurring in the colonic area
what causes the non-specific inflammatory response in UC
abnormal helper Type 2 T cells`
How does UC begin
begins in rectum and goes up through colon
=its retrograde
Signs and symptoms of UC
-abdominal pain, spells of bloody diarhoea varying intensty and duration, interspersed with asymptomatic intervals
-colicky, tenesmus, anaemia due to blood loss, arthrits, skin lesions
GI complications of IBD
Rectal fissures
fistuals (CD)
Perirectal abscess (UC)
Colon cancer (incr. risk): UC, CD
Toxic megacolon
Extraintestinal manifestations of IBD
Hepatobiliary complications
arthrits
uveitis
skin lesions
aphthous ulceration of mouth
Which are the aminosalicylates
Sulfasalazine
Mesalazine (5-ASA): active drug form
What is Sulfasalazine
a prodrug that is metabolized to its active components, Sulfapyridine & 5-ASA; mesalamine
MOA of Sulfasalazine
inhibits leukotrieine synthesis and lipoxygenase= decr. inflammation
Indications of Sulfasalazine
Prolongation of remission in CD and UC
mild to moderate cases
adjunctive therapy in severe cases
CI of Sulfasalazine
history of salicylate or sulphonamine sensitivity
existing gastric or duodenal ulers
DI of Sulfasalazine
Digoxin/folate
iron
methotrexante/phenytoin
warfarin
sulphonylureas